Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer

The emergence of cancer immunotherapies utilizing adoptive cell transfer (ACT) continues to be one of the most promising strategies for cancer treatment. Mast cells (MCs) which occur throughout vascularized tissues, are most commonly associated with Type I hypersensitivity, bind immunoglobin E (IgE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fereydouni, Mohammad, Motaghed, Mona, Ahani, Elnaz, Kafri, Tal, Dellinger, Kristen, Metcalfe, Dean D., Kepley, Christopher L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009255/
https://www.ncbi.nlm.nih.gov/pubmed/35433433
http://dx.doi.org/10.3389/fonc.2022.830199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009255/
https://www.ncbi.nlm.nih.gov/pubmed/35433433
http://dx.doi.org/10.3389/fonc.2022.830199

Ejemplares similares